These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 28394226

  • 1. Stroke in systemic lupus erythematosus and antiphospholipid syndrome: risk factors, clinical manifestations, neuroimaging, and treatment.
    de Amorim LC, Maia FM, Rodrigues CE.
    Lupus; 2017 Apr; 26(5):529-536. PubMed ID: 28394226
    [Abstract] [Full Text] [Related]

  • 2. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U, Yayla ME, Ateş A, Okatan İE, Yurteri EU, Torgutalp M, Keleşoğlu ABD, Turgay TM, Kınıklı G.
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [Abstract] [Full Text] [Related]

  • 3. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J, Cabral AR, Alarcón-Segovia D.
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [Abstract] [Full Text] [Related]

  • 4. Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome).
    Cimaz R, Meroni PL, Shoenfeld Y.
    Lupus; 2006 Oct; 15(4):191-7. PubMed ID: 16686257
    [Abstract] [Full Text] [Related]

  • 5. The interplay between the antiphospholipid syndrome and systemic lupus erythematosus.
    Tincani A, Andreoli L, Chighizola C, Meroni PL.
    Autoimmunity; 2009 May; 42(4):257-9. PubMed ID: 19811269
    [Abstract] [Full Text] [Related]

  • 6. Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus.
    Campos LM, Kiss MH, D'Amico EA, Silva CA.
    Lupus; 2003 May; 12(11):820-6. PubMed ID: 14667097
    [Abstract] [Full Text] [Related]

  • 7. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 8. Cognitive disorders and antiphospholipid antibodies.
    Yelnik CM, Kozora E, Appenzeller S.
    Autoimmun Rev; 2016 Dec; 15(12):1193-1198. PubMed ID: 27639839
    [Abstract] [Full Text] [Related]

  • 9. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome.
    Avcin T, Silverman ED.
    Lupus; 2007 Dec; 16(8):627-33. PubMed ID: 17711899
    [Abstract] [Full Text] [Related]

  • 10. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM.
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antiphospholipid syndrome in systemic lupus erythematosus: is the whole greater than the sum of its parts?
    Laskin CA, Clark CA, Spitzer KA.
    Rheum Dis Clin North Am; 2005 May; 31(2):255-72, vi. PubMed ID: 15922145
    [Abstract] [Full Text] [Related]

  • 14. [Significance of antiphospholipid syndrome and antiphospholipid antibodies in patients with systemic lupus erythematosus in estimation of risk of subclinical atherosclerosis development].
    Fischer K, Brzosko M, Walecka A, Ostanek L, Sawicki M.
    Pol Arch Med Wewn; 2007 May; 117 Suppl():13-7. PubMed ID: 18778013
    [Abstract] [Full Text] [Related]

  • 15. Antibodies and clinical features of the antiphospholipid syndrome as criteria for systemic lupus erythematosus.
    Merrill JT.
    Lupus; 2004 May; 13(11):869-76. PubMed ID: 15580985
    [Abstract] [Full Text] [Related]

  • 16. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
    von Scheven E, Glidden DV, Elder ME.
    Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome.
    Yelnik CM, Kozora E, Appenzeller S.
    Curr Rheumatol Rep; 2016 Feb; 18(2):11. PubMed ID: 26923254
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.